John Burke to Aged
This is a "connection" page, showing publications John Burke has written about Aged.
Connection Strength
0.266
-
Spinal oligodendroglioma: a > 70-year systematic review of current literature. J Neurosurg Spine. 2025 Oct 31; 44(2):272-283.
Score: 0.030
-
Neurocognitive outcomes following adult spinal deformity surgery: a prospective study with 12-month follow-up. Spine J. 2025 Nov; 25(11):2561-2568.
Score: 0.028
-
The correlation of neurosurgery motor examinations with ISNCSCI motor examinations in patients with spinal cord injury: a multicenter TRACK-SCI study. J Neurosurg Spine. 2025 Jan 01; 42(1):120-128.
Score: 0.028
-
Epigenetic age biomarkers and risk assessment in adult spinal deformity: a novel association of biological age with frailty and disability. J Neurosurg Spine. 2024 03 01; 40(3):312-323.
Score: 0.026
-
Association of telomere length with risk of complications in adult spinal deformity surgery: a pilot study of 43 patients. J Neurosurg Spine. 2023 03 01; 38(3):331-339.
Score: 0.024
-
Inferior Clinical Outcomes for Patients with Medicaid Insurance After Surgery for Degenerative Lumbar Spondylolisthesis: A Prospective Registry Analysis of 608 Patients. World Neurosurg. 2022 08; 164:e1024-e1033.
Score: 0.023
-
Elderly traumatic central cord syndrome in the USA: a review of management and outcomes. J Neurosurg Sci. 2021 Aug; 65(4):442-449.
Score: 0.022
-
Evaluating the Clinical Utility and Cost of Imaging Strategies in Adults with Newly Diagnosed Primary Intradural Spinal Tumors. World Neurosurg. 2021 03; 147:e239-e246.
Score: 0.021
-
Delayed Recurrent Laryngeal Nerve Palsy Following Anterior Cervical Discectomy and Fusion. World Neurosurg. 2019 Feb; 122:380-383.
Score: 0.018
-
Predictors of 30-Day Outcomes in Octogenarians with Traumatic C2 Fractures Undergoing Surgery. World Neurosurg. 2018 Aug; 116:e1214-e1222.
Score: 0.018
-
The Accuracy of Multimodality Intraoperative Neuromonitoring to Predict Postoperative Neurologic Deficits Following Cervical Laminoplasty. World Neurosurg. 2017 Oct; 106:17-25.
Score: 0.017
-
Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer. Br J Cancer. 2012 Jan 03; 106(1):70-6.
Score: 0.011